An experimental electric comb helped hair grow across nearly all of a bare patch on mice within four weeks, using electrical pulses to deliver two therapeutic molecules into the skin. The result points to a possible new approach to pattern hair loss, although the treatment has not been shown to work in people.
The system, called Detangle, is described in a study published Nov. 3 in Nature Communications. Researchers led by Beihang University in Beijing, with collaborators including City University of Hong Kong, designed it to address a familiar obstacle in hair-loss treatment: getting active ingredients through the skin to the follicles beneath it.
After 28 days, the full treatment produced nearly complete hair coverage in the measured area, compared with about 70% in mice given topical minoxidil.
How the electric comb works
Detangle combines stimulation with molecular delivery. Its teeth contain electrodes arranged at different heights. Some shorter teeth also hold the experimental treatments, releasing them through a mechanism resembling the rolling tip of a ballpoint pen.
As the device moves over skin, the alternating teeth lift and deform its surface. That geometry strengthens the electric field reaching below the surface, helping the released molecules travel toward the follicles. Electrical pulses can also temporarily make cell membranes more permeable, a process known as electroporation.
The two payloads target different parts of the biology involved in androgenetic alopecia, the medical name for pattern hair loss. A VEGFA plasmid carries instructions intended to encourage blood-vessel growth around follicles. The other molecule, SRD5A2-targeting siRNA, reduces activity in a pathway that produces dihydrotestosterone, or DHT, a hormone involved in follicle shrinkage.
What the mouse experiment measured
The team used young male mice with a laboratory model of androgen-related hair loss. Their back skin was depilated and treated with testosterone to suppress hair growth. Detangle treatment was administered once every three days over 28 days, Medical Xpress reported, consistent with the paper’s methods.
Separating the treatment’s components produced substantially different results. Electrical stimulation alone led to roughly 40% coverage, while untreated animals had about 1%. Adding both molecular treatments produced the near-total coverage reported for the full system.
The questions before human use
The study does not report a human trial. It therefore provides no clinical answer about how well the system reaches human scalp follicles, what dose would be appropriate or whether repeated use of the molecular treatments would be safe.
There are also limits to the experimental design. The authors’ reporting summary says animals were randomized, but sample sizes were not determined in advance. Researchers knew the treatment assignments while collecting data, although image analysis was subsequently blinded using coded images.
Hair-regrowth research has long examined why follicles stop producing normal hair. In 2011, Greek Reporter covered research led by George Cotsarelis at the University of Pennsylvania, which found that balding human scalp retained stem cells but had fewer of the progenitor cells that develop from them.
For the Detangle system, further work would need to establish human safety and effectiveness, how long any regrowth lasts and whether benefits continue after treatment stops.
See all the latest news from Greece and the world at Greekreporter.com. Contact our newsroom to report an update or send your story, photos and videos. Follow GR on Google News and subscribe here to our daily email!

